-

EndoSound™ Inc., Appoints Medical Device Commercial Leader Scott Aldrich Jr as Chief Executive Officer

Aldrich’s proven commercial, operational and leadership expertise helps position EndoSound for EVS launch and sustainable growth

PORTLAND, Ore.--(BUSINESS WIRE)--EndoSound™ Inc., a pioneering medical technology company dedicated to advancing patient care, is pleased to announce the appointment of Scott Aldrich Jr as Chief Executive Officer on February 1st, 2024. Mr Aldrich is joining EndoSound from MotusGI (Nasdaq: MOTS) where he served as Vice President of Commercial and Strategy. Stephen Steinberg MD will remain on the executive leadership team as Chief Medical Officer.

Mr Aldrich brings operational and commercial leadership abilities paired with extensive experience in interventional gastroenterology and medical device imaging. Furthermore, Mr. Aldrich is a seasoned executive with experience in startup organizations, as well as, small/mid cap companies that are both privately and publicly held. He has established a reputation as an authentic leader with the ability to drive execution through clear organizational vision.

Mr Aldrich remarked, “I am honored and humbled to be able to assume the role of CEO. Stephen has done a remarkable job in getting EndoSound so far in its journey. EndoSound EVS™ is a customer-focused product that can reduce aggregate healthcare costs and improve patient experience and lives. It is exciting to be bringing this technology that so clearly can transform the GI market and patient access to endoscopic ultrasound to market. I look forward to working closely with the EndoSound Board of Directors, Stephen, and the rest of the EndoSound team in successfully launching EVS and making the company's immense potential a reality.”

Stephen Steinberg, MD commented, “We are thrilled to welcome Scott to the team. He brings a wealth of knowledge in areas that will be extremely important to EndoSound's success. We believe his leadership style, business acumen and passion make him more than capable to build and grow a revolutionary medical device company.”

About EndoSound

EndoSound, Inc., is a privately held company based in Portland, Oregon. EndoSound is dedicated to expanding access to endoscopic ultrasound technology around the world. With its patented design, EndoSound transforms any flexible upper endoscope into a fully functional EUS scope. It is comprised of an experienced team of scientists and engineers, clinicians, and seasoned business professionals with a track record of bringing new medical devices to market.

To learn more about the EVS, please visit endosound.com.

Contacts

For media inquiries, please contact:
Patrick Hurley
VP of Marketing
pr@endosound.com

EndoSound, Inc.


Release Versions

Contacts

For media inquiries, please contact:
Patrick Hurley
VP of Marketing
pr@endosound.com

More News From EndoSound, Inc.

EndoSound Vision System™ Granted Transitional CMS Pass-Through Code

PORTLAND, Ore.--(BUSINESS WIRE)--EndoSound®, Inc., is thrilled to announce that the Centers for Medicare & Medicaid Services (CMS) has granted a Transitional Pass-Through (TPT) code, effective July 1, 2024, for the company's EndoSound Vision System™, or EVS™, a revolutionary advancement in endoscopic ultrasound (EUS) technology. The CMS TPT status is monumental as it provides outpatient facilities with an incremental Medicare payment for procedures in which the EVS is utilized. This status...

EndoSound® Receives 510(k) Clearance for Breakthrough EVS® Innovation, a novel Endoscopic Ultrasound (EUS) technology

PORTLAND, Ore.--(BUSINESS WIRE)--EndoSound® Inc., a pioneering medical technology company dedicated to advancing patient care, is pleased to announce it has received 510(k) clearance from the FDA for its EndoSound Vision System® (EVS®). This milestone achievement follows the company's FDA Breakthrough Device designation in July 2021, emphasizing the technology's safety features and its potential to enhance access to patient care. The EVS is a novel endoscopic ultrasound (EUS) device that attach...

EndoSound and AdaptivEndo Partner to Revolutionize Endoscopy with Groundbreaking Technologies

PORTLAND, Ore.--(BUSINESS WIRE)--EndoSound, a pioneer in endoscopic ultrasound technology (EUS), and AdaptivEndo, a leader in single-use endoscopy solutions, are proud to announce their letter of intent to collaborate on a new groundbreaking project that aims to transform the landscape of endoscopy. These two innovative companies have come together to expand EndoSound's novel ultrasound technology into the single-use endoscopy space, thus improving patient safety and increasing access to care....
Back to Newsroom
  1. There was an issue with the authorization server. Please contact support if the issue persists.